Valeant will pay $96.25 million, or 33 percent of $290 million total litigation settlement reached by Allergan's shareholders and the company + Bill Ackman's Pershing Square over insider trading claims
Unlock the rest of this article with a 14 day trial
Already have an account?
Login here